A Systematic Review of the Use of Rituximab for Desensitization in Renal Transplantation
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A Systematic Review of the Use of Rituximab for Desensitization in Renal Transplantation
Authors
Keywords
-
Journal
TRANSPLANTATION
Volume 98, Issue 8, Pages 794-805
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2014-08-22
DOI
10.1097/tp.0000000000000362
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Influence of preoperative anti-HLA antibodies on short- and long-term graft survival in recipients with or without rituximab treatment
- (2014) Hideki Ishida et al. TRANSPLANT INTERNATIONAL
- Randomized Controlled Pilot Study of B Cell-Targeted Induction Therapy in HLA Sensitized Kidney Transplant Recipients
- (2013) N. S. Ejaz et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Neither pre-transplant rituximab nor splenectomy affects de novo HLA antibody production after renal transplantation
- (2013) Satoshi Ashimine et al. KIDNEY INTERNATIONAL
- Combined use of rituximab and plasmapheresis pre-transplant increases post-transplant infections in renal transplant recipients with basiliximab induction therapy
- (2013) B.H. Chung et al. Transplant Infectious Disease
- Efficacy, Outcomes, and Cost-Effectiveness of Desensitization Using IVIG and Rituximab
- (2013) Ashley A. Vo et al. TRANSPLANTATION
- Rituximab Prevents an Anamnestic Response in Patients With Cryptic Sensitization to HLA
- (2013) Andrea A. Zachary et al. TRANSPLANTATION
- Quantification of the Early Risk of Death in Elderly Kidney Transplant Recipients
- (2012) J. S. Gill et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Five-Year Outcomes in Living Donor Kidney Transplants With a Positive Crossmatch
- (2012) A. Bentall et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Long-term safety of rituximab in rheumatoid arthritis: 9.5-year follow-up of the global clinical trial programme with a focus on adverse events of interest in RA patients
- (2012) Ronald F van Vollenhoven et al. ANNALS OF THE RHEUMATIC DISEASES
- Significance of low-level DSA detected by solid-phase assay in association with acute and chronic antibody-mediated rejection
- (2012) Toshihito Hirai et al. TRANSPLANT INTERNATIONAL
- The Significance of Low Level DSA Detected by Solid Phase Assay in Association with Acute and Chronic Antibody Mediated Rejection
- (2012) T. Hirai et al. TRANSPLANTATION
- Impact of Pretransplant Rituximab on Kidney Graft in Highly-Sensitized Recipients; Compared with Non-Rituximab Group
- (2012) D. J. Joo et al. TRANSPLANTATION
- Chronic Antibody-Mediated Rejection Is Reduced by Targeting B-Cell Immunity During an Introductory Period
- (2011) N. Kohei et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Infectious Complications in Kidney-Transplant Recipients Desensitized with Rituximab and Intravenous Immunoglobulin
- (2011) J. Kahwaji et al. Clinical Journal of the American Society of Nephrology
- Rapid Oral Sessions
- (2011) TRANSPLANT INTERNATIONAL
- The 5-Year Outcome of ABO-Incompatible Kidney Transplantation With Rituximab Induction
- (2011) Shohei Fuchinoue et al. TRANSPLANTATION
- Retractile mesenteritis in living kidney donors: difficult decision-making
- (2010) Irene Koneth et al. TRANSPLANT INTERNATIONAL
- Evaluation of Low-Dose Rituximab Induction Therapy in Living Related Kidney Transplantation
- (2010) Toshio Takagi et al. TRANSPLANTATION
- Incidence of Infectious Complications in Highly Sensitized Renal Transplant Recipients Treated by Rituximab: A Case-Controlled Study
- (2010) Anne Scemla et al. TRANSPLANTATION
- Combined Posttransplant Prophylactic IVIg/Anti-CD 20/Plasmapheresis in Kidney Recipients With Preformed Donor-Specific Antibodies: A Pilot Study
- (2010) Alexandre Loupy et al. TRANSPLANTATION
- Incidence and Predictive Factors for Infectious Disease after Rituximab Therapy in Kidney-Transplant Patients
- (2009) N. Kamar et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Outcome of Subclinical Antibody-Mediated Rejection in Kidney Transplant Recipients with Preformed Donor-Specific Antibodies
- (2009) A. Loupy et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Centers for Disease Control ‘High-Risk’ Donors and Kidney Utilization
- (2009) K. I. Duan et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Cytomegalovirus infection following renal transplantation in patients administered low-dose rituximab induction therapy
- (2009) Hayato Nishida et al. TRANSPLANT INTERNATIONAL
- ABO-Incompatible Kidney Transplantation Using Antigen-Specific Immunoadsorption and Rituximab: A 3-Year Follow-up
- (2009) Helena Genberg et al. TRANSPLANTATION
- ABO Incompatible Renal Transplantation: A Paradigm Ready for Broad Implementation
- (2009) Robert A. Montgomery et al. TRANSPLANTATION
- Blood Group O Recipients Associated With Early Graft Deterioration in Living ABO-Incompatible Kidney Transplantation
- (2009) Daisuke Toki et al. TRANSPLANTATION
- Complications of Splenectomy
- (2008) Ali Cadili et al. AMERICAN JOURNAL OF MEDICINE
- Incidence of JC-Virus Replication After Rituximab Therapy in Solid-Organ Transplant Patients
- (2008) N. Kamar et al. AMERICAN JOURNAL OF TRANSPLANTATION
- A Randomized, Prospective Trial of Rituximab for Acute Rejection in Pediatric Renal Transplantation
- (2008) V. Zarkhin et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Rituximab and Intravenous Immune Globulin for Desensitization during Renal Transplantation
- (2008) Ashley A. Vo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Impact of low-dose rituximab on splenic B cells in ABO-incompatible renal transplant recipients
- (2008) Daisuke Toki et al. TRANSPLANT INTERNATIONAL
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started